# Fairview Capital Partners

> Fairview Capital Partners is a VC fund backing Health Care and Billing. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: West Hartford, United States
- Total investments: 6
- Last investment: Sep 2025
- Lead investor: 0%
- Fund size: $15M
- Last fund: Feb 2019
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/fairview-capital
- X (Twitter): http://twitter.com/fairviewcapital
- Website: http://fairviewcapital.com/

Fairview Capital Partners is a VC fund in West Hartford focused on Health Care and Billing. We employ private market strategies that reflect the future and harness innovation

## Contacts

5 contacts available for Fairview Capital Partners. Shizune tracks 7 team members at Fairview Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fairview-capital-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| Billing | 1 | 17% |
| FinTech | 1 | 17% |
| Payments | 1 | 17% |
| Software | 1 | 17% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 50% |
| Series A | 1 | 17% |
| Funding Round | 1 | 17% |
| Convertible Note | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alan Mattamana | Partner | 0 | — |
| Edwin Shirley | Partner | 0 | — |
| Joann Price | Co-founder | 0 | — |
| Kolawole Olofinboba | Managing Partner | 0 | — |
| Laurence Morse | Co-Founder | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inbox Health | Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $20M |  | Sep 15, 2025 |  |
| Inbox Health | Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $22.5M | Series B | May 04, 2023 |  |
| Covr Financial Technologies | About Covr Financial TechnologiesFounded in 2016, Covr offers a full suite of digital life insurance platforms, tools and planning services for financial institutions, including: Covr Advisor for financial advisors, Covr Consumer for offering insurance products directly to customers financial institutions and Covr Insights for inforce policymanagement. Covr currently serves over 24,000 financial advisors and 13 million customers across 30 financial institutions including wealth management firms, RIAs, IBDs, banks, credit unions, personal finance apps and P&C agencies. Covr’s investors include leading venture capital firms: Nyca Partners, Commerce Ventures, Allianz Life Ventures, Connectivity Capital Partners, Contour Venture Partners, Connecticut Innovations and Fairview Capital. Covr’s Advisory Board includes financial services leaders including Brian Finn, former president of Credit Suisse First Boston; Sallie Krawcheck, CEO of Elevest and formerly at Citigroup and Smith Barney; Hans Morris, managing partner, Nyca Partners, chairman of Lending Club, formerly president of Visa; Brady Dougan, former CEO of Credit Suisse; Gregg Fleming, CEO of Rockefeller Capital, Bob Kerzner, formerly CEO of LIMRA and Joe Plumeri, formerly of Smith Barney, FirstData and Willis Group. | $15M | Series B | Apr 07, 2022 |  |
| Inbox Health | Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $15M | Series A | Apr 05, 2021 |  |
| Covr Financial Technologies | About Covr Financial TechnologiesFounded in 2016, Covr offers a full suite of digital life insurance platforms, tools and planning services for financial institutions, including: Covr Advisor for financial advisors, Covr Consumer for offering insurance products directly to customers financial institutions and Covr Insights for inforce policymanagement. Covr currently serves over 24,000 financial advisors and 13 million customers across 30 financial institutions including wealth management firms, RIAs, IBDs, banks, credit unions, personal finance apps and P&C agencies. Covr’s investors include leading venture capital firms: Nyca Partners, Commerce Ventures, Allianz Life Ventures, Connectivity Capital Partners, Contour Venture Partners, Connecticut Innovations and Fairview Capital. Covr’s Advisory Board includes financial services leaders including Brian Finn, former president of Credit Suisse First Boston; Sallie Krawcheck, CEO of Elevest and formerly at Citigroup and Smith Barney; Hans Morris, managing partner, Nyca Partners, chairman of Lending Club, formerly president of Visa; Brady Dougan, former CEO of Credit Suisse; Gregg Fleming, CEO of Rockefeller Capital, Bob Kerzner, formerly CEO of LIMRA and Joe Plumeri, formerly of Smith Barney, FirstData and Willis Group. | $7.5M | Convertible Note | Jun 01, 2020 |  |
| Rallybio | Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areasof hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. | $145M | Series B | Apr 14, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 5 deals together
- [Commerce Ventures](https://shizune.co/investors/profile/commerce-ventures) — VC Fund, 4 deals together
- [Healthy Ventures](https://shizune.co/investors/profile/healthy-ventures) — VC Fund, 3 deals together
- [Vertical Venture Partners](https://shizune.co/investors/profile/vertical-venture-partners) — VC Fund, 3 deals together
- [Aflac Global Ventures](https://shizune.co/investors/profile/aflac-corporate-ventures) — VC Fund, 2 deals together
- [Contour Venture Partners](https://shizune.co/investors/profile/contour-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Fairview Capital Partners invest in?

Fairview Capital Partners invests primarily in Health Care, Billing and FinTech startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Fairview Capital Partners?

Public channels for Fairview Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fairview Capital Partners?

The team at Fairview Capital Partners includes Alan Mattamana (Partner), Edwin Shirley (Partner) and Joann Price (Co-founder), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co